Elrexfio

elranatamab-bcmm

Approval

ApplicationBLA 761345
Approval dateAug 14, 2023
Approval year2023
SponsorPfizer INC

FDA-approved use

To treat adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Elrexfio: